Bioporto A/S
CSE:BIOPOR

Watchlist Manager
Bioporto A/S Logo
Bioporto A/S
CSE:BIOPOR
Watchlist
Price: 1.476 DKK 0.68% Market Closed
Market Cap: 634.2m DKK

P/OCF
Price to OCF

-9.2
Current
-9.9
Median
19.8
Industry
Higher than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-9.2
=
Market Cap
634.2m DKK
/
Operating Cash Flow
-68.7m DKK
Market Cap P/OCF
DK
Bioporto A/S
CSE:BIOPOR
634.2m DKK -9.2
FR
Pharnext SCA
OTC:PNEXF
6T USD -228 295.9
US
Abbvie Inc
NYSE:ABBV
378.6B USD 20.1
US
Amgen Inc
NASDAQ:AMGN
170.3B USD 14.8
US
Gilead Sciences Inc
NASDAQ:GILD
139.9B USD 12.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
132B USD -268
US
Epizyme Inc
F:EPE
94.1B EUR -492.8
AU
CSL Ltd
ASX:CSL
121B AUD 26.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
74.4B USD 16.8
US
Seagen Inc
F:SGT
39.3B EUR -79.5
NL
argenx SE
XBRU:ARGX
33.5B EUR -141
 
DK
Bioporto A/S
CSE:BIOPOR
Average P/OCF: 18.2
Negative Multiple: -9.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -228 295.9
US
Abbvie Inc
NYSE:ABBV
20.1
US
Amgen Inc
NASDAQ:AMGN
14.8
US
Gilead Sciences Inc
NASDAQ:GILD
12.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -268
US
E
Epizyme Inc
F:EPE
Negative Multiple: -492.8
AU
CSL Ltd
ASX:CSL
26.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -79.5
NL
argenx SE
XBRU:ARGX
Negative Multiple: -141

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A